Platelet glycoprotein IIb/IIIa receptor antagonist (Abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury

Journal of Surgical Research

Volumn 107, Issue 1, 2002, Pages 50-55

  Kuo, Yur Ren ^a   Jeng, Seng Feng ^a   Wang, Feng Sheng ^a   Huang, Hui Chen ^a   Wei, Fu Chan ^a   Yang, Kuender D ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Abciximab; Ischemia reperfusion injury; Platelet activation; Skin flap survival

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; FIBRINOGEN RECEPTOR ANTAGONIST; PADGEM PROTEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LASER DOPPLER FLOWMETRY; MALE; MOLECULAR BIOLOGY; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; SKIN FLAP SURVIVAL; SURVIVAL RATE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

EID: 0036399778     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2002.6500     Document Type: Article

References (26)

1. Sasaki, G. H., and Pang, C. Y. Hemodynamic and viability of acute neurovascular island skin flaps in rats. Plast. Reconstr. Surg. 65: 152, 1980.
2. Manson, P. N., Anthenelli, R. M., Im, M. J., Bulkley, G. B., and Hoopes, J. E. The role of oxygen free radicals in ischemic tissue injury in island skin flap. Ann. Surg. 198: 87, 1983.
3. Chen, L. Y., Nichols, W. W., Hendricks, J. B., Yang, B. C., and Mehta, J. L. Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc. Res. 28: 1414, 1994.
4. Massberg, S., Enders, G., Leiderer, R., Eisenmenger, S., Vest-weber, D., Krombach, F., and Messmer, K. Platelet-endothelial cell interactions during ischemia/reperfusion: The role of P-selectin. Blood 92: 507, 1998.
5. Johnson, P. C. Platelet-mediated thrombosis in microvascular surgery: New knowledge and strategies. Plast. Reconstr. Surg. 86: 359, 1990.
6. Chintala, M. S., Bernardino, V., and Chiu, P. J. Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats. J. Pharmacol. Exp. Ther. 271: 1203, 1994.
7. Basile, A. P., Fiala, T. G., Yaremchuk, M. J., and May, J. W., Jr. The antithrombotic effects of ticlopidine and aspirin in a microvascular thrombogenic model. Plast. Reconstr. Surg. 95: 1258, 1995.
8. Johnson, P. C., and Barker, J. H. Thrombosis and antithrombotic therapy in microvascular surgery. Clin. Plast. Surg. 19: 799, 1992
9. Topol, E. J. Toward a new frontier in myocardial reperfusion therapy: Emerging platelet preeminence. Circulation 97: 211, 1998.
10. Wencel-Drake, J. D., Plow, E. F., Kunicki, T. J., Woods, V. L., Keller, D. M., and Ginsberg, M. H. Localization of internal pools of membrane glycoproteins involved in platelet adhesive response. Am. J. Pathol. 124: 324, 1986
11. Reverter, J., Beguin, S., Kessels, R., Hemker, H., and Coller, B. Inhibition of platelet-mediated tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. J. Clin. Invest. 98: 863, 1996.
12. Petry, J. J., and Wortham, K. A. The anatomy of the epigastric flap in the experimental rat. Plast. Reconstr. Surg. 74: 410, 1984.
13. Hansen, R. J., and Balthasar, J. P. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: A quantitative rat model of immune thrombocytopenic purpura. J. Pharmacol. Exp. Ther. 298: 165, 2001
14. Sudo, Y., Kilgore, K. S., and Lucchesi, B. R. Monoclonal antibody [7E3(Fab)2] prevent arterial but not venous rethrombosis. J. Cardiovasc. Pharmacol. 26: 241, 1995.
15. Wagner, C. L., Macelli, M. A., Neblock, D. S., Weisman, H. F., Coller, B. S., and Jordan, R. E. Analysis of GP IIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 88: 907, 1996.
16. Ley, K., Bullard, D. C., Arbones, M. L., Bosse, R., Vestweber, D., Tedder, T. F., and Beaudet, A. L. Sequential contribution of L-and P-selectin to leukocyte rolling in vivo. J. Exp. Med. 181: 669, 1995.
17. Diacovo, T. G., Roth, S. J., Buccola, J. M., Bainton, D. F., and Spring, T. A. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88: 146, 1996.
18. Peter, F. W., Franken, R. J., Wang, W. Z., Anderson, G. L., Schuschke, D. A., O'Shaughnessy, M. M., Banis, J. C., Steinau, H. U., and Barker, J. H. Effect of low dose aspirin on thrombus formation at arterial and venous microanastomoses and on the tissue microcirculation. Plast. Reconstr. Surg. 99: 1112, 1997.
19. Rothkopf, D. M., Chu, B., Bern, S., and May, J. W., Jr. The effect of dextran on microvascular thrombosis in an experimental rabbit model. Plast. Reconstr. Surg. 92: 511, 1993.
20. Araki, H., Muramoto, J., Nishi, K., Jougasaki, M., and Inoue, M. Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity. Circ. Res. 71: 577, 1992.
21. Hergrueter, C. A., Handren, J., Kersh, R., and May, J. W., Jr. Human recombinant tissue type plasminogen activator and its effect on microvascular thrombosis in the rabbit. Plast. Reconstr. Surg. 81: 418, 1988.
22. Senderoff, D. M., Zhang, W. X., Israeli, D., Mussat, F., Urken, M. L., and Weinberg, H. The additive beneficial effect of UW solution and urokinase on experimental microvascular free-flap survival. J. Reconstr. Microsurg. 9: 197, 1993.
23. Ferguson, J. J., Kereiakes, D. J., Adgey, A. A., Fox, K. A., Hillegass, W. B., Jr., Pfisterer, M., and Vassanelli, C. Safe use of platelet GP IIb/IIIa inhibitors. Am. Heart J. 135: S77, 1998.
24. Coller, B. S. Blockade of platelet GP IIb/IIIa receptors as an antithrombotic strategy. Circulation 92: 2373, 1995.
25. Scarborough, R. M., Kleiman, N. S., and Philips, D. R. Platelet glycoprotein IIb/IIIa antagonists: What are the relevant issues concerning their pharmacology and clinical use? Circulation 100: 437, 1999.
26. Anderson, H. V., Jordan, R. E., and Weisman, H. F. Concept and clinical application of platelet glycoprotein IIb/IIIa inhibition with abciximab (c7E3 Fab; ReoPro) for the prevention of acute ischemic syndrome. Clin. Appl. Thromb./Hemostasis 3: 256, 1997.